Abstract:The innate and adaptive immune systems act in concert to protect us from infectious agents and other harmful substances. As a state of temporary or permanent immune dysfunction, immunosuppression can make an organism more susceptible to infection, organ injury, and cancer due to damage to the immune system. It takes a long time to develop new immunomodulatory agents to prevent and treat immunosuppressive diseases, with slow progress. Toll-like receptor 2 (TLR2) agonists have been reported as potential immunomodulatory candidates due to their effective activation of immune responses. It has been demonstrated that thymopentin (TP5) could modulate immunity by binding to the TLR2 receptor. However, the fairly short half-life of TP5 greatly reduces its pharmacological potential for immunosuppression therapy. Although peptide cathelicidin 2 (CATH2) has a long half-life, it shows poor immunomodulatory activity and severe cytotoxicity, which seriously hampers its clinical development. Peptide hybridization is an effective approach for the design and engineering of novel functional peptides because hybrid peptides combine the advantages and benefits of various native peptides. In this study, to overcome all these challenges faced by the parental peptides, six hybrid peptides (CaTP, CbTP, CcTP, TPCa, TPCb, and TPCc) were designed by combining the full-length TP5 with different active fragments of CATH2. CbTP, the most potent TLR2 agonist among the six hybrid peptides, was effectively screened through in silico analysis and in vitro experiments. The CbTP peptide exhibited lower cytotoxicity than either CATH2 or TP5. Furthermore, the immunomodulatory effects of CbTP were confirmed in a CTX-immunosuppressed mouse model, which showed that CbTP has increased immunopotentiating activity and physiological stability compared to the parental peptides. CbTP successfully inhibited immunosuppression and weight loss, increased immune organ indices, and improved CD4(+)/CD8(+) T lymphocyte subsets. In addition, CbTP significantly increased the production of the cytokine TNF-alpha and IL-6, and the immunoglobulins IgA, IgM, and IgG. The immunoenhancing effects of CbTP were attributed to its TLR2-binding activity, promoting the formation of the TLR2 cluster, the activation of the TLR2 receptor, and thus activation of the downstream MyD88-NF-kappa B signaling pathway.

The Promotion Of Type 1 T Helper Cell Responses To Cationic Polymers In Vivo Via Toll-Like Receptor-4 Mediated Il-12 Secretion

Tlr Agonists Activate Hpv11 E7-Pulsed Dcs to Promote A Specific T Cell Response in A Murine Model

Stimulation of Toll-Like Receptors profoundly influences the titer of polyreactive antibodies in the circulation

Anti-tumor Immune Responses of Tumor-Associated Macrophages Via Toll-Like Receptor 4 Triggered by Cationic Polymers

Enhanced Immunostimulatory Activity of a Cytosine-Phosphate-Guanosine Immunomodulator by the Assembly of Polymer DNA Wires and Spheres

Macrophage Immunomodulatory Activity of the Cationic Polymer Modified PLGA Nanoparticles Encapsulating Alhagi Honey Polysaccharide.

Immunostimulatory properties of a novel polyphosphoramidate based on stearyl tyrosine

TLR Agonists Inhibit IL-27-Induced HLA-DR Expression in THP-1 Cells

A Toll-like receptor 2 ligand stimulates Th2 responses in vivo, via induction of extracellular signal-regulated kinase mitogen-activated protein kinase and c-Fos in dendritic cells

Understanding How Cationic Polymers’ Properties Inform Toxic or Immunogenic Responses via Parametric Analysis

Stimulation of immune systems by conjugated polymers and their potential as an alternative vaccine adjuvant.

Targeting The Tlr2 Receptor With A Novel Thymopentin-Derived Peptide Modulates Immune Responses

Potent Antigen-specific Immune Responses Stimulated by Codelivery of CpG ODN and Antigens in Degradable Microparticles

Toll-Like Receptor 2 And Toll-Like Receptor 4-Dependent Activation Of B Cells By A Polysaccharide From Marine Fungus Phoma Herbarum Ys4108

Delivery of the TLR Ligand Poly(i:C) to Liver Cells in Vitro and in Vivo by Calcium Phosphate Nanoparticles Leads to a Pronounced Immunostimulation.

Codelivery of Nod2 and Tlr9 Ligands Via Nanoengineered Protein Antigen Particles for Improving and Tuning Immune Responses

Re-Polarizing Myeloid-Derived Suppressor Cells (mdscs) with Cationic Polymers for Cancer Immunotherapy

Polysaccharide of Dendrobium Huoshanense Activates Macrophages Via Toll-Like Receptor 4-Mediated Signaling Pathways

Conventional dendritic cells 2, the targeted antigen-presenting-cell, induces enhanced type 1 immune responses in mice immunized with CVC1302 in oil formulation cDC2 responsible for type 1 immunity induced by CVC1302

TLR3 Activation Efficiency by High or Low Molecular Mass Poly I:C.

Promoting the Activation of T Cells with Glycopolymer-Modified Dendritic Cells by Enhancing Cell Interactions.